When considering the risk stratification of prostate cancer, the diagnostic efficiency of the Ferritin (AUC=0.743), Hepcidin (AUC=0.7) and Fe (AUC=0.771) is further improved, suggesting that even in patients with prostate cancer, different progression often has different iron metabolism. This evidence concerns the gene HAMP and prostate cancer.